Re-irradiation with concurrent pembrolizumab for local-regionally recurrent squamous cell carcinoma of the head and neck

Purpose: To report a single institutional experience with re-irradiation and concurrent pembrolizumab for local-regionally recurrent squamous cell carcinoma of the head and neck. Method and materials: A total of 16 patients were treated with external-beam re-irradiation to median dose of 66 Gy with...

Full description

Bibliographic Details

Published in:	Oral Oncology Reports
Main Authors:	Allen M. Chen, Jeremy P. Harris, Rupali Nabar, Tjoson Tjoa, Yarah Haidar, William B. Armstrong
Format:	Article
Language:	English
Published:	Elsevier 2025-03-01
Subjects:	Re-irradiation Recurrent Head and neck cancer Pembrolizumab Immunotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772906025000020